| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |